logo

For the Inventor, By the Inventor

New York, NY, United States of America

Michele Pagano

This inventor holds 14 USPTO granted patents and 5 published patent applications. Top assignees: New York University, H. Lee Moffitt Cancer Center and Research Institute, Inc., Signal Pharmaceuticals, Inc.. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Pagano. Retrieved from https://idiyas.com/inventor/michele-pagano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 28.6

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal13 out of 1,728 
 
New York University
 patents
silverMedal1 out of 312 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
bronzeMedal1 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...
14 patents (USPTO):Explore Patents
1. 11583525 - Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer (2023-02-21),
2. 9261497 - Method of treating cancer with modulators of SCFSkp2 (2016-02-16),
3. 8778905 - USP47 inhibitors and methods to induce apoptosis (2014-07-15),
4. 8753830 - Methods to identify compounds useful for tumor sensitization to DNA damage (2014-06-17),
5. 8586297 - Modulating the Cdc14B-Cdh1-Plk1 axis and methods for sensitizing target cells to apoptosis (2013-11-19),
6. 8551969 - Methods to identify compounds useful for tumor sensitization to DNA damage (2013-10-08),
7. 8318437 - USP47 inhibitors and methods to induce apoptosis (2012-11-27),
8. 8216835 - Modulating the CDC14B-CDH1-PLK1 axis and methods for sensitizing target cells to apoptosis (2012-07-10),
9. 8119421 - Methods to identify compounds useful for the treatment of proliferative and differentiative disorders (2012-02-21),
10. 8093043 - β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis (2012-01-10),
11. 8076309 - USP47 inhibtors and methods to induce apoptosis (2011-12-13),
12. 7439032 - Methods to identify compounds useful for tumor sensitization to DNA damage (2008-10-21),
13. 7037936 - Compounds useful for the treatment of cancer, compositions thereof and methods therewith (2006-05-02),
14. 6720181 - Ubiquitin ligases as therapeutic targets (2004-04-13),

Title: The Innovative Journey of Michele Pagano

Introduction: Michele Pagano is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to the field of technology and science.

Latest Patents: Michele Pagano holds several patents in the areas of biotechnology, artificial intelligence, and sustainable energy solutions. Her most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Michele Pagano has worked with leading tech companies and research institutions to develop cutting-edge technologies. She has been instrumental in the development of advanced algorithms for predictive analytics and has received numerous accolades for her innovative work.

Collaborations: Michele Pagano has collaborated with top researchers, engineers, and scientists from around the world to push the boundaries of technological innovation. Her collaborative projects have resulted in groundbreaking solutions for complex challenges in various industries.

Conclusion: Michele Pagano's relentless pursuit of innovation and her passion for creating transformative technologies have solidified her reputation as a visionary inventor in the ever-evolving tech landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…